Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
2014 ◽
Vol 32
(15_suppl)
◽
pp. 506-506
◽
2018 ◽
Vol 24
(21)
◽
pp. 5292-5304
◽
Keyword(s):
Keyword(s):
2015 ◽
Keyword(s):